Sletten Cancer Institute is a clinical research site located in Great Falls, Montana, United States 59405.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Sletten Cancer Institute has participated in 5 clinical trials.
Therapeutic areas: Breast Cancer, Breast Neoplasms, Non-Small Cell Lung Cancer.
Sponsors: SCRI Development Innovations, LLC, Novartis Pharmaceuticals, AbbVie.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Sletten Cancer Institute has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sletten Cancer Institute has 5 clinical trials on record. Their work covers Breast Cancer, Breast Neoplasms, Non-Small Cell Lung Cancer.
Yes — Sletten Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.